QUAY STEVEN C
SEC insider (Form 3/4/5 filer). CIK 0001008227. President & CEO at ATOSSA THERAPEUTICS, INC. (ATOS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2026. Located in SEATTLE, WA.
Companies QUAY STEVEN C has filed insider reports for
- ATOSSA THERAPEUTICS, INC. (ATOS): Director, Officer, President & CEO
QUAY STEVEN C
CIK: 0001008227
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATOS
ATOSSA THERAPEUTICS, INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 20, 2026ATOS
ATOSSA THERAPEUTICS, INC.
AwardDirect331.7K shares- - Jan 20, 2026ATOS
ATOSSA THERAPEUTICS, INC.
AwardDirect325.2K shares- - May 21, 2025ATOS
ATOSSA THERAPEUTICS, INC.
PurchaseDirect11.2K shares at avg. $0.88$10K - May 15, 2025ATOS
ATOSSA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
1.4M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | Award | 331,674 | - | $0 | Direct |
| Jan 20, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | Award | 325,203 | - | $0 | Direct |
| May 21, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | Purchase | 11,239 | $0.88 | $9,887 | Direct |
| May 15, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 1,366,062 | - | - | Direct |
1-4 of 4 transactions